Filings under AVIR by Vaxart, Inc. (CIK 0000072444) from May 12, 2016 to Feb 13, 2018 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Adams Jerome M. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Adams Jerome M. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Adams Jerome M. | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Adams Jerome M. | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Lucidi Bruno | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Lucidi Bruno | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Lucidi Bruno | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Lucidi Bruno | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Kirsch Arthur S | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Kirsch Arthur S | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Murphy Polly A. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Murphy Polly A. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Murphy Polly A. | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Murphy Polly A. | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Polsky Bruce | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Polsky Bruce | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Polsky Bruce | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Polsky Bruce | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Duncan Barbara Gayle | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Duncan Barbara Gayle | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Duncan Barbara Gayle | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Duncan Barbara Gayle | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Berman Howard | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Berman Howard | Director | Grant(A) | 38K | — | $0 |
| Jun 18, 2026 | Berger Franklin M | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Berger Franklin M | Director | Option exercise(M) | 30K | — | $0 |
| Jun 18, 2026 | Berger Franklin M | Director | Grant(A) | 27K | — | $0 |
| Jun 18, 2026 | Berger Franklin M | Director | Grant(A) | 38K | — | $0 |
| May 18, 2026 | Murphy Polly A. | Director | Buy(P) | 6K | $4.17 | $25K |
| Mar 11, 2026 | Corcoran Andrea | See Remarks | Option exercise(M) | 60K | $1.24 | $74K |
| Mar 11, 2026 | Corcoran Andrea | See Remarks | Option exercise(M) | 60K | — | $0 |
| Feb 3, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 300K | $1.24 | $372K |
| Feb 3, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 300K | — | $0 |
| Jan 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | Tax withholding(F) | 12K | $4.24 | $51K |
| Jan 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | Option exercise(M) | 41K | — | — |
| Jan 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | Option exercise(M) | 33K | — | $0 |
| Jan 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | Option exercise(M) | 8K | — | $0 |
| Jan 31, 2026 | Foster Wayne | EVP, Chief Accounting Officer | Grant(A) | 108K | — | $0 |
| Jan 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Tax withholding(F) | 106K | $4.24 | $450K |
| Jan 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 273K | — | — |
| Jan 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 173K | — | $0 |
| Jan 31, 2026 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 100K | — | $0 |
| Jan 31, 2026 | Corcoran Andrea | See Remarks | Option exercise(M) | 55K | — | — |
| Jan 31, 2026 | Corcoran Andrea | See Remarks | Tax withholding(F) | 16K | $4.24 | $68K |
| Jan 31, 2026 | Corcoran Andrea | See Remarks | Grant(A) | 180K | — | $0 |
| Jan 31, 2026 | Corcoran Andrea | See Remarks | Option exercise(M) | 44K | — | $0 |
| Jan 31, 2026 | Corcoran Andrea | See Remarks | Option exercise(M) | 11K | — | $0 |
| Jan 31, 2026 | Hammond Janet MJ | Chief Development Officer | Option exercise(M) | 58K | — | — |
| Jan 31, 2026 | Hammond Janet MJ | Chief Development Officer | Tax withholding(F) | 14K | $4.24 | $60K |
| Jan 31, 2026 | Hammond Janet MJ | Chief Development Officer | Option exercise(M) | 11K | — | $0 |
| Jan 31, 2026 | Hammond Janet MJ | Chief Development Officer | Option exercise(M) | 47K | — | $0 |
| Jan 31, 2026 | Hammond Janet MJ | Chief Development Officer | Grant(A) | 177K | — | $0 |
| Jan 31, 2026 | Vavricka John | Chief Commercial Officer | Tax withholding(F) | 12K | $4.24 | $49K |
| Jan 31, 2026 | Vavricka John | Chief Commercial Officer | Option exercise(M) | 42K | — | — |
| Jan 31, 2026 | Vavricka John | Chief Commercial Officer | Option exercise(M) | 9K | — | $0 |
| Jan 31, 2026 | Vavricka John | Chief Commercial Officer | Grant(A) | 120K | — | $0 |
| Jan 31, 2026 | Vavricka John | Chief Commercial Officer | Option exercise(M) | 33K | — | $0 |
| Jan 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | Tax withholding(F) | 16K | $4.24 | $68K |
| Jan 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | Option exercise(M) | 51K | — | — |
| Jan 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | Option exercise(M) | 42K | — | $0 |
| Jan 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | Option exercise(M) | 10K | — | $0 |
| Jan 31, 2026 | Horga Maria Arantxa | Chief Medical Officer | Grant(A) | 174K | — | $0 |
| Jun 20, 2025 | Berman Howard | Director | Grant(A) | 165K | — | $0 |
| Jun 20, 2025 | Lucidi Bruno | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Lucidi Bruno | Director | Grant(A) | 41K | — | $0 |
| Jun 20, 2025 | Lucidi Bruno | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2025 | Lucidi Bruno | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Polsky Bruce | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Polsky Bruce | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Polsky Bruce | Director | Grant(A) | 41K | — | $0 |
| Jun 20, 2025 | Polsky Bruce | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2025 | Berger Franklin M | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Berger Franklin M | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Berger Franklin M | Director | Grant(A) | 41K | — | $0 |
| Jun 20, 2025 | Berger Franklin M | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2025 | Murphy Polly A. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Murphy Polly A. | Director | Grant(A) | 41K | — | $0 |
| Jun 20, 2025 | Murphy Polly A. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Murphy Polly A. | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2025 | Adams Jerome M. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Adams Jerome M. | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Adams Jerome M. | Director | Grant(A) | 41K | — | $0 |
| Jun 20, 2025 | Adams Jerome M. | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2025 | Duncan Barbara Gayle | Director | Option exercise(M) | 30K | — | $0 |
| Jun 20, 2025 | Duncan Barbara Gayle | Director | Grant(A) | 41K | — | $0 |
| Jun 20, 2025 | Duncan Barbara Gayle | Director | Grant(A) | 30K | — | $0 |
| Jun 20, 2025 | Duncan Barbara Gayle | Director | Option exercise(M) | 30K | — | $0 |
| Feb 20, 2025 | Kirsch Arthur S | Director | Grant(A) | 165K | — | $0 |
| Jan 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | Option exercise(M) | 33K | — | — |
| Jan 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | Grant(A) | 8K | — | — |
| Jan 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | Tax withholding(F) | 12K | $3.06 | $37K |
| Jan 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | Option exercise(M) | 33K | — | $0 |
| Jan 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | Grant(A) | 8K | — | $0 |
| Jan 31, 2025 | Foster Wayne | EVP, Chief Accounting Officer | Grant(A) | 120K | — | $0 |
| Jan 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Grant(A) | 100K | — | — |
| Jan 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 173K | — | — |
| Jan 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Tax withholding(F) | 89K | $3.06 | $271K |
| Jan 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Grant(A) | 440K | — | $0 |
| Jan 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Grant(A) | 100K | — | $0 |
| Jan 31, 2025 | Sommadossi Jean-Pierre | President, CEO, and Chairman, Director | Option exercise(M) | 173K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Atea Pharmaceuticals, Inc., SEC CIK 0001593899. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AVIR and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AVIR